Hyperglycemia related to high-dose glucocorticoid use in noncritically ill patients

Diabetology and Metabolic Syndrome

Volumn 5, Issue 1, 2013, Pages

  Gonzalez Gonzalez, Jose Gerardo ^a   Mireles Zavala, Leonor Guadalupe ^a   Rodriguez Gutierrez, Rene ^a   Gomez Almaguer, David ^a   Lavalle Gonzalez, Fernando Javier ^a   Tamez Perez, Hector Eloy ^a   Gonzalez Saldivar, Gerardo ^a   Villarreal Perez, Jesus Zacarias ^a  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

Author keywords

Diabetes; Drug induced diabetes; Glucocorticoid; Glucocorticoid induced diabetes; Hyperglycemia; Secondary diabetes

Indexed keywords

GLUCOSE; INSULIN; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; DIABETES MELLITUS; DIET RESTRICTION; DRUG MEGADOSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INCIDENCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RISK FACTOR;

EID: 84875690170     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-5-18     Document Type: Article

References (25)

1. Diagnosis and classification of diabetes mellitus. American Diabetes Association, Diabetes Care 2012 35 Suppl 1 64 71 22187472
2. Drug-induced diabetes mellitus. Izzedine H, Expert Opin Drug Saf 2005 4 1097 109 10.1517/14740338.4.6.1097 16255667 (Pubitemid 41671606)
3. Risk of diabetes associated with prescribed glucocorticoids in a large population. Gulliford M, Charlton J, Latinovic R, Diabetes Care 2006 29 2728 29 10.2337/dc06-1499 17130214 (Pubitemid 44912208)
4. Mechanisms involved in the side effects of glucocorticoids. Schäcke H, Döcke WD, Asadullah K, Pharmacol Ther 2002 96 23 43 10.1016/S0163- 7258(02)00297-8 12441176 (Pubitemid 35346616)
5. Hiperglucemia inducida por glucocorticoides. Saigí Ullastre I, Pérez PA, Semin Fund Esp Reumatol 2011 12 83 90 10.1016/j.semreu.2011.04. 004
6. Drug-induced disorders of glucose tolerance. Pandit M, Burke J, Gustafson A, Minocha A, Peiris A, Ann Intern Med 1993 118 529 39 10.7326/0003-4819-118-7- 199304010-00008 8442624 (Pubitemid 23085796)
7. Glucocorticoid-induced hyperglycemia. Clore JN, Thurby-Hay L, Endocr Pract 2009 15 469 74 10.4158/EP08331.RAR 19454391
8. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action. Rizza RA, Mandarino LJ, Gerich JE, J Clin Endocrinol Metab 1982 54 131 8 10.1210/jcem-54-1-131 7033265 (Pubitemid 13242146)
9. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Donihi AC, Raval D, Salul M, Korytkowski MT, DeVita MA, Endocr Pract 2006 12 358 62 10.4158/EP.12.4.358 16901792 (Pubitemid 44717593)
10. Posttransplantation diabetes. A systematic review of the literature. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC, Diabetes Care 2002 25 583 92 10.2337/diacare.25.3.583 11874952
11. Steroid-induced diabetes mellitus and related risk factors in patients with neurologic diseases. Iwamoto T, Kagawa Y, Naito Y, Pharmacotherapy 2004 24 508 14 10.1592/phco.24.5.508.33355 15098806 (Pubitemid 38420539)
12. Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases. Uzu T, Harada T, Sakaguchi M, Nephron Clin Pract 2007 105 54 c57 10.1159/000097598 17135768 (Pubitemid 46143906)
13. Increased risk of post-transplant diabetes mellitus despite early steroid discontinuation in Hispanic kidney transplant recipients. Walczak DA, Calvert D, Jarzembowski TM, Testa G, Clin Transplant 2005 19 527 31 10.1111/j.1399-0012. 2005.00383.x 16008600 (Pubitemid 40990665)
14. Glucocorticoid-induced diabetes mellitus in patients with systemic lupus erythematosus treated with high-dose glucocorticoid therapy. Ha YJ, Lee KH, Jung SJ, Lupus 2011 20 1027 34 10.1177/0961203311402246 21659423
15. Incidence and risk factors of steroid-induced diabetes in patients with respiratory disease. Kim SY, Yoo CG, Lee CT, Chung HS, J Korean Med Sci 2011 26 264 7 10.3346/jkms.2011.26.2.264 21286019
16. Post-transplant hyperglycemia: a study of risk factors. Mathew JT, Rao M, Job V, Ratnaswamy S, Jacob CK, Nephrol Dial Transplant 2003 18 164 71 10.1093/ndt/18.1.164 12480976 (Pubitemid 36104494)
17. Managing diabetes during glucocorticoid therapy. How to avoid metabolic emergencies. Braithwaite SS, Barr WG, Rahman A, Quddusi S, Postgrad Med 1998 104 163 6 9823393
18. Targeting plasma glucose: preprandial versus postprandial. Schrot JR, Clinical Diabetes 2004 22 4 169 172 10.2337/diaclin.22.4.169
19. The homeostasis model in the San Antonio heart study. Haffner SM, Miettinen H, Stern MP, Diabetes Care 1997 20 1087 92 10.2337/diacare.20.7.1087 9203442 (Pubitemid 27274268)
20. Glucocorticoid-induced diabetes and adrenal suppression: How to detect and manage them. Lansang MC, Hustak LK, Cleve Clin J Med 2011 78 748 56 10.3949/ccjm.78a.10180 22049542
21. Steroid-induced diabetic ketoacidosis. Haggerty RD, Bergsman K, Edelson GW, Pract Diabetol 1995 14 24 5
22. Hyperosmolar non-ketotic state as first manifestation of diabetes mellitus. Kirkman MS, Wittle B, Benzing M, Diabetes Spectr 1997 10 175 6
23. Glucocorticoid-induced diabetic ketoacidosis in acute rheumatic fever. Cagdas DN, Aysenur Pac F, Cakal E, J Cardiovasc Pharmacol Ther 2008 13 298 300 10.1177/1074248408326609 19087951
24. Steroid diabetes in children with Crohn disease. Banac S, Persic M, Cvijovic K, Acta Med Croatica 2002 56 35 8 12455453 (Pubitemid 35278117)
25. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, Seley JJ, J Clin Endocrinol Metab 2012 97 16 38 10.1210/jc.2011-2098 22223765